|
시장보고서
상품코드
2054657
경구 피임약 시장 : 정제 유형별, 호르몬 조성별, 용량별, 프로게스틴 세대별, 사용자 연령층별, 처방 상황별, 브랜드 유형별, 용도별, 포장 형태별, 유통 채널별, 지역별Contraceptive Pills Market, By Pill Category, By Hormonal Composition,By Dosage Strength, By Progestin Generation, By User Age Group, By Prescription Status, By Brand Type,By Application Need,By Packaging Format, By Distribution Channel, By Geography |
||||||
경구 피임약 시장은 2026년에 87억 1,000만 달러로 추계되고 있으며, 2033년까지 142억 7,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 7.3%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 87억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 7.30% | 2033년 시장 규모 예측 : | 142억 7,000만 달러 |
세계 경구 피임약 시장은 생식 건강 산업에서 중요한 분야로, 호르몬 조절 메커니즘을 통해 원치 않는 임신을 예방하도록 설계된 경구 피임약을 포함합니다. 주로 합성 에스트로겐과 프로게스틴 호르몬을 함유한 이러한 의약품은 배란을 억제하고, 자궁경부 점액의 점도를 변화시키며, 자궁내막을 변화시킴으로써 수정에 대한 여러 가지 장벽을 형성하는 작용을 합니다.
이 시장은 1960년대에 최초의 경구 피임약이 출시된 이래 크게 발전해 왔습니다. 기본적인 호르몬 제제에서, 유효성을 유지하면서 부작용을 최소화하는 정교한 저용량 복합제로 변모하고 있습니다. 현대 경구 피임약은 에스트로겐과 프로게스틴을 모두 함유한 복합형 피임약과 프로게스틴 단독 피임약으로 분류되며, 각각 서로 다른 환자군에게 고유한 이점을 제공합니다.
이 업계는 단상형, 2상형, 3상형 피임약, 장기 복용형, 응급 경구 피임약 등 다양한 제형을 통해 소비자의 다양한 요구에 부응하고 있습니다. 이 시장은 제약사, 의료 종사자, 규제 당국, 최종사용자를 아우르는 복잡한 생태계 속에서 운영되고 있으며, 유통 채널은 병원, 클리닉, 약국, 그리고 점점 더 늘어나고 있는 온라인 플랫폼에 달합니다. 경구 피임약 시장은 편의성 향상, 부작용 완화, 그리고 피임 이외의 치료 효과 증대 등 끊임없이 변화하는 소비자의 요구에 부응함으로써, 헬스케어 분야의 혁신을 지속적으로 주도하고 있습니다.
시장 역학
세계 경구 피임약 시장은 상호 연관된 여러 요인의 견인 속에 견고한 성장세를 보이고 있습니다. 특히 정부가 피임 수단에 대한 접근성을 높이고 피임 방법에 대한 이해를 증진시키는 교육 프로그램을 추진하고 있는 개발도상국 지역에서, 가족 계획 및 생식 건강에 대한 의식의 향상가 시장 확대의 주요 원동력이 되고 있습니다.
전 세계 여성의 경제활동 참여율 상승은 여성들이 자신의 경력 목표에 맞춰 임신을 계획할 수 있도록 해주는 신뢰할 수 있는 피임법에 대한 수요를 창출하고 있습니다. 한편, 여성의 역량 강화와 생식권리에 대한 관심이 높아짐에 따라 피임법의 보급률은 더욱 가속화되고 있습니다. 많은 국가에서 의료 인프라가 개선되고 경구 피임약의 보험 적용 범위가 확대됨에 따라 시장 침투가 가속화되고 있으며, 이는 호르몬 투여량 감소 및 새로운 투여 기전을 통해 부작용을 완화하고 사용자 경험을 향상시키는 지속적인 제품 혁신에 힘입은 바 큽니다.
그러나 시장에는 중대한 제약도 존재합니다. 보수적인 사회에서 피임 사용에 대한 문화적·종교적 반대는 특정 지역의 시장 침투를 제한하고 있습니다. 또한 혈전, 심혈관 합병증, 기분 장애 위험 증가 등 경구 피임약의 장기 복용과 관련된 안전성 우려로 인해 잠재적 사용자와 의료 종사자들 사이에서 주저하는 분위기가 형성되고 있습니다.
경구 피임약 승인 절차의 엄격한 규제 요건은 개발 비용과 시장 출시까지의 기간을 늘리고 있습니다. 한편, 자궁내 피임기구, 임플란트, 장벽법 등의 대체 피임법의 보급은 경쟁을 심화시키고 있습니다. 큰 기회는 젊은 인구가 증가하고 있지만 서비스가 충분히 제공되지 않는 신흥 시장, 신기술을 통해 가능해진 맞춤형 호르몬 요법, 그리고 여드름, 자궁내막증, 다낭성난소증후군(PCOS)에 대한 피임약의 폭넓은 치료 용도에 있으며, 이는 총 잠재 시장(TAM)을 확대하고 새로운 수입원을 개발할 것입니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 경구 피임약 시장의 주요 기업 개요을 작성했습니다. : 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 경구 피임약 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 경구 피임약 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 경구 피임약 시장 : 정제 유형별, 2021-2033년
제5장 세계의 경구 피임약 시장 : 호르몬 조성별, 2021-2033년
제6장 세계의 경구 피임약 시장 : 용량별, 2021-2033년
제7장 세계의 경구 피임약 시장 : 프로게스틴 세대별, 2021-2033년
제8장 세계의 경구 피임약 시장 : 사용자 연령층별, 2021-2033년
제9장 세계의 경구 피임약 시장 : 처방 상황별, 2021-2033년
제10장 세계의 경구 피임약 시장 : 브랜드 유형별, 2021-2033년
제11장 세계의 경구 피임약 시장 : 용도별, 2021-2033년
제12장 세계의 경구 피임약 시장 : 포장 형태별, 2021-2033년
제13장 세계의 경구 피임약 시장 : 유통 채널별, 2021-2033년
제14장 세계의 경구 피임약 시장 : 지역별, 2021-2033년
제15장 경쟁 구도
제16장 애널리스트의 제안
제17장 참고 문헌 및 조사 방법
KSA 26.06.17Contraceptive Pills Market is estimated to be valued at USD 8.71 Bn in 2026 and is expected to reach USD 14.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.71 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.30% | 2033 Value Projection: | USD 14.27 Bn |
The global contraceptive pills market represents a critical segment of the reproductive health industry, encompassing oral contraceptive medications designed to prevent unwanted pregnancies through hormonal regulation mechanisms. These pharmaceutical products, primarily containing synthetic versions of estrogen and progestin hormones, work by suppressing ovulation, altering cervical mucus consistency, and modifying the uterine lining to create multiple barriers against conception.
The market has evolved significantly since the introduction of the first oral contraceptive in the 1960s, transforming from basic hormonal formulations to sophisticated, low-dose combinations that minimize side effects while maintaining efficacy. Modern contraceptive pills are categorized into combination pills containing both estrogen and progestin, and progestin-only pills, each offering distinct advantages for different patient demographics.
The industry serves diverse consumer needs through various formulations including monophasic, biphasic, and triphasic pills, extended-cycle options, and emergency contraceptives. This market operates within a complex ecosystem involving pharmaceutical manufacturers, healthcare providers, regulatory bodies, and end-users, with distribution channels spanning hospitals, clinics, pharmacies, and increasingly, online platforms. The contraceptive pills market continues to drive innovation in reproductive healthcare, addressing evolving consumer preferences for convenience, reduced side effects, and enhanced therapeutic benefits beyond contraception.
Market Dynamics
The global contraceptive pills market experiences robust growth driven by multiple interconnected factors, with increasing awareness about family planning and reproductive health serving as the primary catalyst for market expansion, particularly in developing regions where government initiatives promote contraceptive accessibility and education programs enhance understanding of birth control options.
Rising female workforce participation globally creates demand for reliable contraceptive methods that enable women to plan pregnancies according to career goals, while growing emphasis on women's empowerment and reproductive rights further accelerates adoption rates. Healthcare infrastructure improvements and expanding insurance coverage for contraceptives in many countries facilitate market penetration, supported by continuous product innovations that reduce side effects and improve user experience through lower hormone doses and novel delivery mechanisms.
However, the market faces significant restraints including cultural and religious opposition to contraceptive use in conservative societies, which limits market penetration in certain geographic regions, while safety concerns regarding long-term hormonal contraceptive use, including increased risks of blood clots, cardiovascular complications, and mood disorders, create hesitancy among potential users and healthcare providers.
Stringent regulatory requirements for contraceptive approval processes increase development costs and time-to-market, while the availability of alternative contraceptive methods such as intrauterine devices, implants, and barrier methods intensifies competitive pressure. Significant opportunities lie in underserved emerging markets with rising youth populations, personalized hormone solutions enabled by new technologies, and broader therapeutic uses of contraceptive pills for acne, endometriosis, and PCOS, which expand the total addressable market and unlock new revenue streams.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global contraceptive pills market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, Bayer AG, Organon & Co, Teva Pharmaceutical Industries Ltd, Mylan NV (Viatris Inc), Johnson & Johnson, Gedeon Richter Plc, Lupin Limited, Cipla Limited, HLL Lifecare Limited, Piramal Enterprises Limited, Sun Pharmaceutical Industries Ltd, Allergan plc (AbbVie Inc), Cadila Healthcare Ltd (Zydus Lifesciences), and Torrent Pharmaceuticals Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global contraceptive pills market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive pills market
Market Segmentation
- Pill Category Insights (Revenue, USD Bn, 2021 - 2033)
- Combined oral contraceptive pills (COCs)
- Progestin-only pills (POPs/mini-pills)
- Emergency contraceptive pills (ECPs)
- Hormonal Composition Insights (Revenue, USD Bn, 2021 - 2033)
- Monophasic Pills
- Biphasic Pills
- Triphasic Pills
- Dosage Strength Insights (Revenue, USD Bn, 2021 - 2033)
- Low-Dose Pills
- Standard-Dose Pills
- High-Dose Pills
- Progestin Generation Insights (Revenue, USD Bn, 2021 - 2033)
- First-Generation Progestin Pills
- Second-Generation Progestin Pills
- Third-Generation Progestin Pills
- Fourth-Generation Progestin Pills
- User Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- 15-19 years
- 20-29 years
- 30-39 years
- 40+ years
- Prescription Status Insights (Revenue, USD Bn, 2021 - 2033)
- Prescription-Based Pills
- Over-the-Counter Pills
- Brand Type Insights (Revenue, USD Bn, 2021 - 2033)
- Generic
- Branded
- Application Need Insights (Revenue, USD Bn, 2021 - 2033)
- Birth Control
- Hormonal Regulation
- Acne Management
- Menstrual Cycle Management
- Packaging Format Insights (Revenue, USD Bn, 2021 - 2033)
- 21-Day Pack
- 24-Day Pack
- 28-Day Pack
- 91-Day Pack
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Bayer AG
- Organon & Co
- Teva Pharmaceutical Industries Ltd
- Mylan NV (Viatris Inc)
- Johnson & Johnson
- Gedeon Richter Plc
- Lupin Limited
- Cipla Limited
- HLL Lifecare Limited
- Piramal Enterprises Limited
- Sun Pharmaceutical Industries Ltd
- Allergan plc (AbbVie Inc)
- Cadila Healthcare Ltd (Zydus Lifesciences)
- Torrent Pharmaceuticals Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Contraceptive Pills Market, By Pill Category
- Global Contraceptive Pills Market, By Hormonal Composition
- Global Contraceptive Pills Market, By Dosage Strength
- Global Contraceptive Pills Market, By Progestin Generation
- Global Contraceptive Pills Market, By User Age Group
- Global Contraceptive Pills Market, By Prescription Status
- Global Contraceptive Pills Market, By Brand Type
- Global Contraceptive Pills Market, By Application Need
- Global Contraceptive Pills Market, By Packaging Format
- Global Contraceptive Pills Market, By Distribution Channel
- Global Contraceptive Pills Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Contraceptive Pills Market, By Pill Category, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Combined oral contraceptive pills (COCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Progestin-only pills (POPs/mini-pills)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Emergency contraceptive pills (ECPs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Contraceptive Pills Market, By Hormonal Composition, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Monophasic Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biphasic Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Triphasic Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Contraceptive Pills Market, By Dosage Strength, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Low-Dose Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Standard-Dose Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High-Dose Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Contraceptive Pills Market, By Progestin Generation, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- First-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Second-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Third-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fourth-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Contraceptive Pills Market, By User Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 15-19 years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 20-29 years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 30-39 years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 40+ years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Contraceptive Pills Market, By Prescription Status, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription-Based Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Over-the-Counter Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Contraceptive Pills Market, By Brand Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Contraceptive Pills Market, By Application Need, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Birth Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hormonal Regulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acne Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Menstrual Cycle Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Contraceptive Pills Market, By Packaging Format, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 21-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 24-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 28-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 91-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
13. Global Contraceptive Pills Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
14. Global Contraceptive Pills Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Pill Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Pill Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Pill Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Pill Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Pill Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Pill Category, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
15. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organon & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan NV (Viatris Inc)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gedeon Richter Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HLL Lifecare Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Piramal Enterprises Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan plc (AbbVie Inc)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cadila Healthcare Ltd (Zydus Lifesciences)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Torrent Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
17. References and Research Methodology
- References
- Research Methodology
- About us
